United States
Germany
Japan
United Kingdom
China
MAP2K1 (MEK1) mouse monoclonal antibody, clone OTI4E4 (formerly 4E4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Antibodies
DEF6 mouse monoclonal antibody, clone OTI2G2 (formerly 2G2)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
RIPK1 (RIP) mouse monoclonal antibody, clone OTI2G3 (formerly 2G3)
| Applications | IHC, WB |
| Reactivities | Human, Dog |
UBE2G2 mouse monoclonal antibody, clone OTI1G10 (formerly 1G10)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
CD44 mouse monoclonal antibody, clone OTI5B5 (formerly 5B5)
| Applications | IHC, WB |
| Reactivities | Human, Dog |
CD44 mouse monoclonal antibody, clone OTI5C1 (formerly 5C1)
| Applications | IHC, WB |
| Reactivities | Human, Dog |
AP2M1 mouse monoclonal antibody, clone OTI1E9 (formerly 1E9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K3 (MEK3) mouse monoclonal antibody, clone OTI1B5 (formerly 1B5)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
MAP2K3 (MEK3) mouse monoclonal antibody, clone OTI4G4 (formerly 4G4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Mouse |
UBE2G2 mouse monoclonal antibody, clone OTI4A12 (formerly 4A12)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
KLK8 (Kallikrein 8) mouse monoclonal antibody, clone OTI2C6 (formerly 2C6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Monkey |
Anti-USP5 mouse monoclonal antibody, clone OTI1F8 (formerly 1F8)
| Applications | IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Anti-RAD9A (RAD9) mouse monoclonal antibody, clone OTI5D9 (formerly 5D9)
| Applications | IHC, WB |
| Reactivities | Human, Dog, Monkey |
Beta-catenin mouse monoclonal antibody, clone OTI1F3 (formerly 1F3)
| Applications | IHC, WB |
| Reactivities | Human, Dog, Monkey, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Target Symbol
- MEK1 (50)
- UBE2G2 (35)
- MEK3 (25)
- BETA CATENIN (15)
- SH3PX1 (15)
- USP5 (15)
- CD44 (10)
- ERK2 (10)
- ESTROGEN RECEPTOR 1 (10)
- HSP60 (10)
- KALLIKREIN 8 (10)
- ADH1B (5)
- AK3 (5)
- ALDH1L1 (5)
- AP2M1 (5)
- BCAT1 (5)
- BECLIN 1 (5)
- BETA IV TUBULIN (5)
- BTN1A1 (5)
- CALPAIN 2 (5)
- CYTOCHROME P450 2B6 (5)
- CYTOKERATIN 8 (5)
- DEF6 (5)
- DPP9 (5)
- EPOXIDE HYDROLASE (5)
- FMRP (5)
- GAD67 (5)
- GLB1 (5)
- IDURONATE 2 SULFATASE (5)
- LEUKOTRIENE A4 HYDROLASE (5)
- LIM KINASE 1 (5)
- MEK2 (5)
- N CADHERIN (5)
- NYREN18 (5)
- OSGEP (5)
- PANK2 (5)
- PFDN3 (5)
- PIK3R5 (5)
- PROFILIN 1 (5)
- PSMC3 (5)
- PSMD2 (5)
- PTP1B (5)
- RAB30 (5)
- RAD9 (5)
- RASD2 (5)
- RIP (5)
- RPA34 (5)
- TUBA8 (5)
- TUBB1 (5)
- USP9X (5)
- XPNPEP3 (5)
Antibody Hosts
Knockout (KO) Validation
Conjugates
Clonalities
Pathways
- Toll-like receptor signaling pathway (100)
- Fc epsilon RI signaling pathway (95)
- GnRH signaling pathway (90)
- MAPK signaling pathway (90)
- Endometrial cancer (85)
- Focal adhesion (85)
- Pathways in cancer (85)
- Prostate cancer (85)
- Colorectal cancer (80)
- Gap junction (80)
- Melanogenesis (80)
- Regulation of actin cytoskeleton (80)
- Thyroid cancer (80)
- Insulin signaling pathway (75)
- Acute myeloid leukemia (70)
- B cell receptor signaling pathway (70)
- Chronic myeloid leukemia (70)
- ErbB signaling pathway (70)
- Fc gamma R-mediated phagocytosis (70)
- Glioma (70)
- Melanoma (70)
- Natural killer cell mediated cytotoxicity (70)
- Neurotrophin signaling pathway (70)
- Non-small cell lung cancer (70)
- Renal cell carcinoma (70)
- T cell receptor signaling pathway (70)
- VEGF signaling pathway (70)
- Bladder cancer (65)
- Chemokine signaling pathway (65)
- Long-term depression (65)
- Long-term potentiation (65)
- Pancreatic cancer (65)
- Prion diseases (65)
- Progesterone-mediated oocyte maturation (65)
- Vascular smooth muscle contraction (65)
- Dorso-ventral axis formation (60)
- Oocyte meiosis (60)
- Metabolic pathways (40)
- Parkinson's disease (35)
- Ubiquitin mediated proteolysis (35)
- Adherens junction (30)
- Pathogenic Escherichia coli infection (30)
- Amyotrophic lateral sclerosis (ALS) (25)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (20)
- Leukocyte transendothelial migration (20)
- Alzheimer's disease (15)
- Apoptosis (15)
- Axon guidance (15)
- Basal cell carcinoma (15)
- Metabolism of xenobiotics by cytochrome P450 (15)
- Tight junction (15)
- Type I diabetes mellitus (15)
- Type II diabetes mellitus (15)
- Wnt signaling pathway (15)
- mTOR signaling pathway (15)
- Arachidonic acid metabolism (10)
- Drug metabolism - cytochrome P450 (10)
- ECM-receptor interaction (10)
- Glycosaminoglycan degradation (10)
- Hematopoietic cell lineage (10)
- Lysosome (10)
- NOD-like receptor signaling pathway (10)
- Pantothenate and CoA biosynthesis (10)
- Proteasome (10)
- RNA degradation (10)
- Retinol metabolism (10)
- TGF-beta signaling pathway (10)
- Alanine (5)
- Butanoate metabolism (5)
- Cell adhesion molecules (CAMs) (5)
- Cytosolic DNA-sensing pathway (5)
- DNA replication (5)
- Endocytosis (5)
- Fatty acid metabolism (5)
- Galactose metabolism (5)
- Glycolysis / Gluconeogenesis (5)
- Glycosphingolipid biosynthesis - ganglio series (5)
- Homologous recombination (5)
- Huntington's disease (5)
- Jak-STAT signaling pathway (5)
- Mismatch repair (5)
- Nucleotide excision repair (5)
- One carbon pool by folate (5)
- Other glycan degradation (5)
- Phosphatidylinositol signaling system (5)
- Pyrimidine metabolism (5)
- RIG-I-like receptor signaling pathway (5)
- Regulation of autophagy (5)
- Small cell lung cancer (5)
- Sphingolipid metabolism (5)
- Taurine and hypotaurine metabolism (5)
- Tyrosine metabolism (5)
- Valine (5)
- aspartate and glutamate metabolism (5)
- beta-Alanine metabolism (5)
- leucine and isoleucine biosynthesis (5)
- leucine and isoleucine degradation (5)
